期刊
SPINAL CORD
卷 44, 期 2, 页码 78-81出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.sc.3101784
关键词
circadian; melatonin; polysomnography; tetraplegia; sleep; spinal cord injuries
资金
- NCRR NIH HHS [M01-RR-02635, M01 RR002635] Funding Source: Medline
- NHLBI NIH HHS [K24 HL076446-04, K24 HL076446, R01 HL064815, HL-64815] Funding Source: Medline
Study design: Case-controlled preliminary observational study. Objective: Melatonin is usually secreted only at night and may influence sleep. We previously found that complete cervical spinal cord injury (SCI) interrupts the neural pathway required for melatonin secretion. Thus, we investigated whether the absence of night time melatonin in cervical SCI leads to sleep disturbances. Setting: General Clinical Research Center, Brigham & Women's Hospital, Boston, USA. Methods: In an ancillary analysis of data collected in a prior study, we assessed the sleep patterns of three subjects with cervical SCI plus absence of nocturnal melatonin ( SCI levels: C4A, C6A, C6/7A) and two control patients with thoracic SCI plus normal melatonin rhythms ( SCI levels: T4A, T5A). We also compared those results to the sleep patterns of 10 healthy control subjects. Results: The subjects with cervical SCI had significantly lower sleep efficiency ( median 83%) than the control subjects with thoracic SCI (93%). The sleep efficiency of subjects with thoracic SCI was not different from that of healthy control subjects (94%). There was no difference in the proportion of the different sleep stages, although there was a significantly increased REM-onset latency in subjects with cervical SCI ( 220 min) as compared to subjects with thoracic SCI ( 34 min). The diminished sleep in cervical SCI was not associated with sleep apnea or medication use. Conclusion: We found that cervical SCI is associated with decreased sleep quality. A larger study is required to confirm these findings. If confirmed, the absence of night time melatonin in cervical SCI may help explain their sleep disturbances, raising the possibility that melatonin replacement therapy could help normalize sleep in this group. Sponsorship: This work was supported by the NIH (GCRC Grant M01-RR-02635 and Grant HL-64815). Dr Ayas is supported by the BCLA, CIHR, and MSFHR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据